Cholesterol and Heart Disease: The Evidence on Diet, Blood Lipids, Eggs, and Lipid-Lowering Therapy

Cholesterol and Heart Disease: An Evidence-Based Review of Diet, Blood Lipids, and Treatment

The conclusion in one sentence

The relationship between cholesterol and heart disease must be interpreted in the context of overall cardiovascular risk: prolonged exposure to higher LDL promotes atherosclerosis, and lowering LDL reduces cardiovascular events, but neither dietary advice nor medication can be applied indiscriminately without considering the population for whom it is appropriate. PMID: 28444290 PMID: 30712900

First, distinguish cholesterol from LDL and HDL

Cholesterol in the diet is a food component; LDL and HDL on a laboratory report are lipoproteins that transport lipids. Calling all of them “cholesterol” is convenient in everyday conversation, but it can create the mistaken impression that ingested cholesterol directly becomes a particular laboratory value. Professor Lin has long urged readers to distinguish these concepts, and that central message is consistent with the literature. More precisely, LDL and HDL are lipoproteins, not merely proteins. PMID: 26109578 PMID: 30403574

The significance of LDL does not lie in a single isolated high or low measurement, but in the exposure to atherogenic lipoproteins that it represents. The totality of genetic, epidemiologic, and randomized lipid-lowering trial evidence supports LDL as a causal factor in atherosclerotic cardiovascular disease. By contrast, higher HDL is not necessarily always better. Extremely high HDL has been associated with adverse outcomes in certain populations, but findings vary among populations, and an HDL value alone cannot establish causality. PMID: 28444290 PMID: 35039162 PMID: 39368903

Dietary cholesterol: neither harmless nor intelligible as an isolated nutrient

Removing a fixed intake limit does not mean that dietary cholesterol has become “beneficial and harmless.” The literature indicates that dietary cholesterol may raise blood lipid levels and that individual responses differ. Findings on cardiovascular events are also affected by the overall diet, the foods substituted for one another, and the limitations of observational research. Professor Lin therefore had reasonable grounds for rejecting claims that dietary cholesterol is entirely harmless. The literature has since been updated, however, and it likewise does not justify telling everyone, without qualification, that lower intake is always better. PMID: 26109578 PMID: 37706071

The more consistent message is that diet quality matters more than the labels “low carbohydrate” or “low fat.” Healthful versions rich in high-quality plant foods, whole grains, and unsaturated fats are associated with a lower risk of coronary heart disease, whereas versions composed of refined carbohydrates or lower-quality foods may show the opposite pattern. These prospective cohort data demonstrate associations, however; by themselves, they cannot prove that a particular food directly caused an outcome. PMID: 41670561

Eggs: neither glorify nor demonize them

Research on eggs and cardiovascular disease has long produced divergent findings. Some studies report unfavorable associations, while others find neutral or apparently favorable results. This is precisely the coexistence of evidence on both sides that Professor Lin described. The most prudent practical interpretation is that moderate consumption has limited effects for most people, but eggs should not be promoted as a food that prevents heart disease. People at higher cardiometabolic risk must still evaluate eggs within the context of their entire diet and medical risk profile. PMID: 32132002 PMID: 41062520 PMID: 41497962

Regarding fat composition, an earlier article compared egg yolk with lard and olive oil. In light of updated literature, the point can now be stated more precisely: egg yolk does contain monounsaturated fat, but the mere presence of oleic acid does not warrant the leap to claiming that egg yolk prevents heart disease. Likewise, a single classification of fat should not determine the risk that eggs pose to every individual. PMID: 40803220 PMID: 41918140

Wood ear mushrooms may be eaten, but they are not a treatment for “unblocking blood vessels”

Responding to an online rumor, Professor Lin’s original article noted that the physiological role of vitamin K is to participate in coagulation; it is not the anticoagulant constituent of wood ear mushrooms. Subsequent research continues to attribute the relevant activity of wood ear mushrooms to polysaccharides. A mechanistic finding is not equivalent to clinical efficacy: current antithrombotic evidence remains predominantly in vitro or animal-based. It therefore cannot support claims that eating wood ear mushrooms clears vascular blockages, nor can these mushrooms replace treatments supported by human trials. PMID: 42123580 PMID: 35956781

Lipid-lowering drugs: effective, but not a single prescription for everyone

Statins reduce major cardiovascular events, supporting their cardioprotective role. Preventive benefit, however, depends on a person’s pre-existing disease and baseline risk; “effective” must not be translated into a recommendation that everyone take a statin for life. Findings from trials of more intensive LDL lowering in people who have experienced an acute coronary event or already have atherosclerotic cardiovascular disease also cannot be used directly to define normal values for generally healthy people. PMID: 41864911 PMID: 30403574 PMID: 42100682

Statins lower circulating coenzyme Q concentrations, but this does not prove that every muscular symptom is caused by coenzyme Q deficiency. Evidence remains inconsistent as to whether supplementation relieves symptoms. The more appropriate course is for a healthcare professional to assess the symptoms, medications, and other possible causes, rather than for a patient to stop treatment independently or regard a supplement as essential. PMID: 39795963 PMID: 41158831

Updated literature has also qualified the broad assertion that “lowering LDL to a very low level is necessarily dangerous.” In studies of selected high-risk patients, very low LDL did not produce the conspicuous harms implied by that claim and was accompanied by fewer cardiovascular endpoints. This still cannot be extrapolated in reverse to mean that everyone should pursue an extremely low value. Treatment goals must remain anchored to the studied population and the individual’s risk. PMID: 28291866

Aspirin is an antiplatelet drug, not an everyday wellness product

Aspirin prevents thrombotic events by inhibiting platelet-related pathways and is well supported for secondary prevention in people with established coronary heart disease. It is not a tool that directly “dissolves” existing plaque to open an artery, and its principal costs include gastrointestinal bleeding. Whether to use it, combine it with another antiplatelet drug, or discontinue it must be determined by the clinical context. Updated literature shows that aspirin can be deliberately adjusted in certain combination-treatment settings, so the instruction “never stop it” cannot be applied to every patient. PMID: 42279109 PMID: 42479073 PMID: 41550254

How to apply the evidence to yourself

First determine whether the issue under discussion is a food, a laboratory marker, disease risk, or a treatment target. Then distinguish among cellular studies, animal experiments, observational cohorts, and randomized clinical trials. A mechanism associated with one food does not mean that the food treats disease; an association between a single measurement and an outcome does not make that measurement the same risk threshold for everyone. The most reliable decisions arise when a qualified healthcare professional evaluates established cardiovascular disease, the overall diet, blood lipids, and bleeding risk together.